SPAAC Click Reaction
Strain-promoted azide-alkyne cycloaddition (SPAAC) click reaction was popularized in 2004 by Bertozzi, a famous organic chemist and molecular cell biologist in the United States. This reaction occurs between an azide and a cycloalkyne by ring strain rather than copper catalysts to form a stable triazole. The schematic diagram of the SPAAC click reaction is shown in scheme 1.
Scheme 1. Schematic diagram of the SPAAC click reaction.
Advantages
SPAAC click reaction does not require metal catalysts, reducing agents, or stable ligands. Instead, it only relies on the enthalpy released from the ring strain of cyclooctyne to form a stable triazole. Thus, SPAAC click reaction has many advantages, including but not limited to the following.
- High yield: SPAAC click reaction has no by-products, so the yield is very high.
- Low toxicity: SPAAC click reaction does not involve metal catalysts that may cause biotoxicity by releasing metal ions, so the reaction is low toxicity.
- High selectivity: SPAAC click reaction is inert to acids, oxides, and active amino acid molecules, so it has high selectivity.
- Others: Other advantages of SPAAC click reaction include mild reaction conditions, high reaction rate, and good biorthogonality.
Applications
SPAAC click reaction has been extensively used in many fields such as polymer chemistry and medicine. The details are as follows.
- In polymer chemistry
- In medicine
What Can We Do?
As a leading customer-focused company, Alfa Chemistry has experienced experts and professional R & D laboratories. For many years, we have been focusing on reagent development and potential application exploration of the SPAAC click reaction. If you have questions about the SPAAC click reaction, please contact us. We will draw upon our wide range of advantages and high-quality products to create customized, scalable, efficient solutions for your research.
Reference
- Derks, Y.H.W.; et al. Strain-promoted azide-alkyne cycloaddition-based PMSA-targeting ligands for multimodal intraoperative tumor detection of prostate cancer. Bioconjugate Chemistry. 2022, 33: 194-205.
Please kindly note that our products and services are for research use only.